Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases
Publication date: October 2026 Source: Research and Practice in Thrombosis and Haemostasis, Volume 10, Issue 7 Author(s): Lucie Raskin, Marie Didembourg, Médéa Locquet, Laure Morimont, Charlotte Beaudart, Jean-Michel Dogné, Jonathan Douxfils
Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926036630?dgcid=rss_sd_all
Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926036630?dgcid=rss_sd_all
“Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases.” Research and Practice in Thrombosis and Haemostasis.
@article{article64529,
title = {Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926036630?dgcid=rss_sd_all}
}